Daxor Corporation (DXR)
USD 8.2
(-0.97%)
USD 8.2
(-0.97%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.28 Million USD | 448.16% |
| 2022 | 6.31 Million USD | 8.4% |
| 2021 | 5.82 Million USD | 684.28% |
| 2020 | -996.29 Thousand USD | -766.41% |
| 2019 | -114.99 Thousand USD | 87.48% |
| 2018 | -918.44 Thousand USD | 9.21% |
| 2017 | -1.01 Million USD | -155.12% |
| 2016 | 1.83 Million USD | 124.66% |
| 2015 | -7.44 Million USD | -83.63% |
| 2014 | -4.05 Million USD | 64.93% |
| 2013 | -11.55 Million USD | -449.78% |
| 2012 | -2.1 Million USD | -264.57% |
| 2011 | 1.27 Million USD | -19.11% |
| 2010 | 1.57 Million USD | -6.49% |
| 2009 | 1.68 Million USD | -4.1% |
| 2008 | 1.76 Million USD | -5.81% |
| 2007 | 1.86 Million USD | 25.79% |
| 2006 | 1.48 Million USD | 10.64% |
| 2005 | 1.34 Million USD | 10.27% |
| 2004 | 1.21 Million USD | -61.51% |
| 2003 | 3.16 Million USD | 17.15% |
| 2002 | 2.7 Million USD | 256.28% |
| 2001 | 758.36 Thousand USD | 1.69% |
| 2000 | 745.78 Thousand USD | 29.62% |
| 1999 | 575.37 Thousand USD | 91.79% |
| 1998 | 300 Thousand USD | -40.0% |
| 1997 | 500 Thousand USD | -82.14% |
| 1996 | 2.8 Million USD | -40.43% |
| 1995 | 4.7 Million USD | 2.17% |
| 1994 | 4.6 Million USD | -4.17% |
| 1993 | 4.8 Million USD | -21.31% |
| 1992 | 6.1 Million USD | 56.41% |
| 1991 | 3.9 Million USD | -15.22% |
| 1990 | 4.6 Million USD | 109.09% |
| 1989 | 2.2 Million USD | -50.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 35.87 Thousand USD | 0.0% |
| 2024 Q1 | 35.87 Thousand USD | -99.9% |
| 2023 Q3 | 41.22 Thousand USD | 102.34% |
| 2023 Q1 | 40.48 Thousand USD | 112.49% |
| 2023 FY | 34.59 Million USD | 448.16% |
| 2023 Q4 | 36.35 Million USD | 88078.72% |
| 2023 Q2 | -1.76 Million USD | -4448.4% |
| 2022 Q4 | -324.14 Thousand USD | -772.5% |
| 2022 Q3 | 48.19 Thousand USD | 264.97% |
| 2022 Q1 | 67.62 Thousand USD | 105.47% |
| 2022 FY | 6.31 Million USD | 8.4% |
| 2022 Q2 | -29.21 Thousand USD | -143.21% |
| 2021 Q3 | 76.21 Thousand USD | 105.53% |
| 2021 Q2 | -1.37 Million USD | -2295.77% |
| 2021 FY | 5.82 Million USD | 684.28% |
| 2021 Q4 | -1.23 Million USD | -1721.2% |
| 2021 Q1 | 62.82 Thousand USD | 104.23% |
| 2020 Q1 | 59.47 Thousand USD | -97.0% |
| 2020 Q2 | -1.32 Million USD | -2320.43% |
| 2020 FY | -996.29 Thousand USD | -766.41% |
| 2020 Q3 | 72.74 Thousand USD | 105.51% |
| 2020 Q4 | -1.48 Million USD | -2142.4% |
| 2019 Q3 | 93.6 Thousand USD | 137.93% |
| 2019 FY | -114.99 Thousand USD | 87.48% |
| 2019 Q1 | 96.46 Thousand USD | -3.75% |
| 2019 Q2 | -246.79 Thousand USD | -355.85% |
| 2019 Q4 | 1.98 Million USD | 2018.54% |
| 2018 Q1 | 114.76 Thousand USD | -16.63% |
| 2018 Q3 | 100.21 Thousand USD | -12.67% |
| 2018 Q4 | 100.21 Thousand USD | 0.0% |
| 2018 FY | -918.44 Thousand USD | 9.21% |
| 2018 Q2 | 114.76 Thousand USD | 0.0% |
| 2017 Q3 | 137.65 Thousand USD | -0.29% |
| 2017 Q4 | 137.65 Thousand USD | 0.0% |
| 2017 FY | -1.01 Million USD | -155.12% |
| 2017 Q1 | 138.05 Thousand USD | 6.13% |
| 2017 Q2 | 138.05 Thousand USD | 0.0% |
| 2016 Q2 | 136.73 Thousand USD | 0.0% |
| 2016 FY | 1.83 Million USD | 124.66% |
| 2016 Q4 | 130.07 Thousand USD | 0.0% |
| 2016 Q3 | 130.07 Thousand USD | -4.87% |
| 2016 Q1 | 136.73 Thousand USD | -30.72% |
| 2015 FY | -7.44 Million USD | -83.63% |
| 2015 Q3 | 197.35 Thousand USD | -39.58% |
| 2015 Q4 | 197.35 Thousand USD | 0.0% |
| 2015 Q2 | 326.63 Thousand USD | 0.0% |
| 2015 Q1 | 326.63 Thousand USD | -21.92% |
| 2014 Q2 | 387.96 Thousand USD | 0.0% |
| 2014 FY | -4.05 Million USD | 64.93% |
| 2014 Q1 | 387.96 Thousand USD | -26.23% |
| 2014 Q4 | 418.31 Thousand USD | 0.0% |
| 2014 Q3 | 418.31 Thousand USD | 7.82% |
| 2013 Q4 | 525.9 Thousand USD | 0.0% |
| 2013 Q1 | 497.86 Thousand USD | -16.77% |
| 2013 FY | -11.55 Million USD | -449.78% |
| 2013 Q3 | 525.9 Thousand USD | 5.63% |
| 2013 Q2 | 497.86 Thousand USD | 0.0% |
| 2012 FY | -2.1 Million USD | -264.57% |
| 2012 Q4 | 598.16 Thousand USD | 0.0% |
| 2012 Q3 | 598.16 Thousand USD | 0.0% |
| 2011 Q1 | 377.46 Thousand USD | 4.45% |
| 2011 Q3 | 311.13 Thousand USD | 12.37% |
| 2011 Q4 | 342.58 Thousand USD | 10.11% |
| 2011 FY | 1.27 Million USD | -19.11% |
| 2011 Q2 | 276.87 Thousand USD | -26.65% |
| 2010 FY | 1.57 Million USD | -6.49% |
| 2010 Q4 | 361.37 Thousand USD | -20.28% |
| 2010 Q3 | 453.28 Thousand USD | 23.06% |
| 2010 Q2 | 368.33 Thousand USD | -7.05% |
| 2010 Q1 | 396.27 Thousand USD | -13.85% |
| 2009 Q4 | 459.99 Thousand USD | 11.01% |
| 2009 FY | 1.68 Million USD | -4.1% |
| 2009 Q1 | 434.03 Thousand USD | 30.62% |
| 2009 Q2 | 380.42 Thousand USD | -12.35% |
| 2009 Q3 | 414.37 Thousand USD | 8.93% |
| 2008 Q1 | 420.91 Thousand USD | -10.26% |
| 2008 Q3 | 451.25 Thousand USD | -18.92% |
| 2008 Q4 | 332.3 Thousand USD | -26.36% |
| 2008 FY | 1.76 Million USD | -5.81% |
| 2008 Q2 | 556.58 Thousand USD | 32.23% |
| 2007 Q2 | 545.31 Thousand USD | 7.8% |
| 2007 FY | 1.86 Million USD | 25.79% |
| 2007 Q3 | 349.54 Thousand USD | -35.9% |
| 2007 Q1 | 505.88 Thousand USD | 51.08% |
| 2007 Q4 | 469.03 Thousand USD | 34.18% |
| 2006 Q1 | 342.14 Thousand USD | -23.32% |
| 2006 Q4 | 334.84 Thousand USD | -20.3% |
| 2006 Q3 | 420.14 Thousand USD | 7.92% |
| 2006 Q2 | 389.32 Thousand USD | 13.79% |
| 2006 FY | 1.48 Million USD | 10.64% |
| 2005 Q1 | 296.58 Thousand USD | 115.09% |
| 2005 Q2 | 270.65 Thousand USD | -8.74% |
| 2005 Q3 | 340.79 Thousand USD | 25.91% |
| 2005 Q4 | 446.17 Thousand USD | 30.92% |
| 2005 FY | 1.34 Million USD | 10.27% |
| 2004 Q2 | 933.23 Thousand USD | -17.45% |
| 2004 Q3 | 1.11 Million USD | 19.96% |
| 2004 Q4 | -1.96 Million USD | -275.51% |
| 2004 FY | 1.21 Million USD | -61.51% |
| 2004 Q1 | 1.13 Million USD | 50.34% |
| 2003 Q4 | 751.97 Thousand USD | -16.83% |
| 2003 FY | 3.16 Million USD | 17.15% |
| 2003 Q3 | 904.18 Thousand USD | 17.17% |
| 2003 Q1 | 737.61 Thousand USD | 49.7% |
| 2003 Q2 | 771.66 Thousand USD | 4.62% |
| 2002 Q1 | 661.83 Thousand USD | 152.8% |
| 2002 Q4 | 492.74 Thousand USD | -37.96% |
| 2002 Q2 | 753.08 Thousand USD | 13.79% |
| 2002 FY | 2.7 Million USD | 256.28% |
| 2002 Q3 | 794.27 Thousand USD | 5.47% |
| 2001 Q2 | 679.58 Thousand USD | 4.94% |
| 2001 Q1 | 647.62 Thousand USD | 328.66% |
| 2001 FY | 758.36 Thousand USD | 1.69% |
| 2001 Q4 | -1.25 Million USD | -283.09% |
| 2001 Q3 | 684.59 Thousand USD | 0.74% |
| 2000 FY | 745.78 Thousand USD | 29.62% |
| 2000 Q2 | 150.43 Thousand USD | -36.26% |
| 2000 Q1 | 236 Thousand USD | 213.1% |
| 2000 Q3 | 182.47 Thousand USD | 21.3% |
| 2000 Q4 | 151.08 Thousand USD | -17.21% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 FY | 575.37 Thousand USD | 91.79% |
| 1999 Q4 | 75.37 Thousand USD | -62.31% |
| 1999 Q3 | 200 Thousand USD | 100.0% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q4 | - USD | -100.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 FY | 300 Thousand USD | -40.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q2 | 100 Thousand USD | -50.0% |
| 1997 Q1 | 200 Thousand USD | -66.67% |
| 1997 FY | 500 Thousand USD | -82.14% |
| 1997 Q4 | 100 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q3 | 800 Thousand USD | 0.0% |
| 1996 Q2 | 800 Thousand USD | 33.33% |
| 1996 Q1 | 600 Thousand USD | -53.85% |
| 1996 FY | 2.8 Million USD | -40.43% |
| 1996 Q4 | 600 Thousand USD | -25.0% |
| 1995 FY | 4.7 Million USD | 2.17% |
| 1995 Q3 | 1 Million USD | -9.09% |
| 1995 Q2 | 1.1 Million USD | -8.33% |
| 1995 Q1 | 1.2 Million USD | 0.0% |
| 1995 Q4 | 1.3 Million USD | 30.0% |
| 1994 FY | 4.6 Million USD | -4.17% |
| 1994 Q4 | 1.2 Million USD | 20.0% |
| 1994 Q3 | 1 Million USD | -16.67% |
| 1994 Q2 | 1.2 Million USD | 9.09% |
| 1994 Q1 | 1.1 Million USD | -26.67% |
| 1993 Q2 | 1.4 Million USD | 180.0% |
| 1993 Q4 | 1.5 Million USD | -6.25% |
| 1993 Q1 | 500 Thousand USD | 400.0% |
| 1993 Q3 | 1.6 Million USD | 14.29% |
| 1993 FY | 4.8 Million USD | -21.31% |
| 1992 FY | 6.1 Million USD | 56.41% |
| 1992 Q4 | 100 Thousand USD | -94.12% |
| 1992 Q3 | 1.7 Million USD | -39.29% |
| 1992 Q2 | 2.8 Million USD | 75.0% |
| 1992 Q1 | 1.6 Million USD | 60.0% |
| 1991 Q3 | 1 Million USD | 100.0% |
| 1991 Q4 | 1 Million USD | 0.0% |
| 1991 Q1 | 1 Million USD | -41.18% |
| 1991 Q2 | 500 Thousand USD | -50.0% |
| 1991 FY | 3.9 Million USD | -15.22% |
| 1990 FY | 4.6 Million USD | 109.09% |
| 1990 Q3 | 1 Million USD | 0.0% |
| 1990 Q2 | 1 Million USD | 0.0% |
| 1990 Q1 | 1 Million USD | 42.86% |
| 1990 Q4 | 1.7 Million USD | 70.0% |
| 1989 FY | 2.2 Million USD | -50.0% |
| 1989 Q2 | 600 Thousand USD | 0.0% |
| 1989 Q1 | 600 Thousand USD | -45.45% |
| 1989 Q3 | 400 Thousand USD | -33.33% |
| 1989 Q4 | 700 Thousand USD | 75.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 98.675% |
| AngioDynamics, Inc. | 303.91 Million USD | 99.579% |
| AtriCure, Inc. | 399.24 Million USD | 99.679% |
| Avinger, Inc. | 7.65 Million USD | 83.266% |
| Azenta, Inc. | 665.07 Million USD | 99.807% |
| BioLife Solutions, Inc. | 143.27 Million USD | 99.106% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.964% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | 92.995% |
| Femasys Inc. | 1.07 Million USD | -19.454% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 98.859% |
| Hologic, Inc. | 4.03 Billion USD | 99.968% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.943% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.982% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 95.51% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 99.338% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -11.11% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -11.11% |
| Masimo Corporation | 2.04 Billion USD | 99.937% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 98.681% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 99.898% |
| Nephros, Inc. | 14.23 Million USD | 91.006% |
| NovoCure Limited | 509.33 Million USD | 99.749% |
| NEXGEL, Inc. | 4.08 Million USD | 68.684% |
| NEXGEL, Inc. | 4.08 Million USD | 68.684% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | 56.011% |
| OraSure Technologies, Inc. | 405.47 Million USD | 99.684% |
| Pro-Dex, Inc. | 53.84 Million USD | 97.622% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | 28.065% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | 93.297% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.957% |
| Repligen Corporation | 638.76 Million USD | 99.8% |
| Sanara MedTech Inc. | 64.98 Million USD | 98.03% |
| STAAR Surgical Company | 322.41 Million USD | 99.603% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 97.45% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.968% |
| Jin Medical International Ltd. | 19.82 Million USD | 93.54% |